Chairman of the Board and CEO of BioScrip Inc. (BIOS, Financial) Richard H Friedman sells 8,302 shares of BIOS on 11/16/2009 at an average price of $9 a share.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $327.7 million; its shares were traded at around $8.45 with a P/E ratio of 20.1 and P/S ratio of 0.2.
BioScrip provides comprehensive pharmaceutical care solutions. We partner with healthcare payors, pharmaceutical manufacturers, government agencies, physicians, and patients to deliver cost effective programs that enhance the quality of patient life. We focus our products and services in two core areas: specialty medication distribution and clinical management services, both nationally and community-based and pharmacy benefit management services. Bioscrip Inc. has a market cap of $327.7 million; its shares were traded at around $8.45 with a P/E ratio of 20.1 and P/S ratio of 0.2.
Insiders' Positions with BIOS
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 85,000 shares of BIOS stock on 11/09/2009 at the average price of 8.01, the price of the stock has increased by 5.49% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 58,000 shares of BIOS stock on 11/04/2009 at the average price of 7.73, the price of the stock has increased by 9.31% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 7,861 shares of BIOS stock on 10/14/2009 at the average price of 7, the price of the stock has increased by 20.71% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 22,139 shares of BIOS stock on 10/08/2009 at the average price of 7, the price of the stock has increased by 20.71% since
- Sell:: Chairman of the Board and CEO Richard H Friedman sold 30,000 shares of BIOS stock on 10/01/2009 at the average price of 6.63, the price of the stock has increased by 27.45% since
Insiders' Positions with BIOS
- Sell:: Executive Vice President Thomas Ordemann sold 41,260 shares of BIOS stock on 11/11/2009 at the average price of 8.56, the price of the stock has decreased by 1.29% since
- Sell:: Vice President Mail Operations Russel J Corvese sold 17,839 shares of BIOS stock on 08/26/2009 at the average price of 6.13, the price of the stock has increased by 37.85% since
- Sell:: Executive Vice President Scott Friedman sold 21,096 shares of BIOS stock on 08/11/2009 at the average price of 5.9, the price of the stock has increased by 43.22% since
- Sell:: Executive Vice President Scott Friedman sold 3,904 shares of BIOS stock on 08/06/2009 at the average price of 6.05, the price of the stock has increased by 39.67% since
- Sell:: Executive Vice President Barry A Posner sold 50,000 shares of BIOS stock on 08/04/2009 at the average price of 6.24, the price of the stock has increased by 35.42% since
